Toll Free: 1-888-928-9744

Retrophin Inc. - Product Pipeline Review - 2014

Published: Nov, 2014 | Pages: 35 | Publisher: Global Markets Direct
Industry: Pharmaceutical | Report Format: Electronic (PDF)

Retrophin Inc. - Product Pipeline Review - 2014

Summary

Global Markets Direct's, 'Retrophin Inc. - Product Pipeline Review - 2014', provides an overview of the Retrophin Inc.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Retrophin Inc.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides brief overview of Retrophin Inc. including business description, key information and facts, and its locations and subsidiaries
- The report reviews current pipeline of Retrophin Inc.'s human therapeutic division and enlists all their major and minor projects
- The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones 
- Special feature on out-licensed and partnered product portfolio
- The report summarizes all the dormant and discontinued pipeline projects
- Latest company statement 
- Latest news and deals relating to the Retrophin Inc.'s pipeline products

Reasons to buy

- Evaluate Retrophin Inc.'s strategic position with total access to detailed information on its product pipeline
- Assess the growth potential of Retrophin Inc. in its therapy areas of focus
- Identify new drug targets and therapeutic classes in the Retrophin Inc.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
- Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
- Develop strategic initiatives by understanding the focus areas of Retrophin Inc. and exploit collaboration and partnership opportunities
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Plan mergers and acquisitions effectively by identifying the most promising pipeline of Retrophin Inc.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Explore the dormant and discontinued projects of Retrophin Inc. and identify potential opportunities in those areas
- Avoid Intellectual Property Rights related issues
 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Retrophin Inc. Snapshot 5
Retrophin Inc. Overview 5
Key Information 5
Key Facts 5
Retrophin Inc. - Research and Development Overview 6
Key Therapeutic Areas 6
Retrophin Inc. - Pipeline Review 8
Pipeline Products by Stage of Development 8
Pipeline Products - Monotherapy 9
Pipeline Products - Partnered Products 10
Partnered Products/Combination Treatment Modalities 11
Retrophin Inc. - Pipeline Products Glance 12
Retrophin Inc. - Late Stage Pipeline Products 12
Phase III Products/Combination Treatment Modalities 12
Retrophin Inc. - Clinical Stage Pipeline Products 13
Phase II Products/Combination Treatment Modalities 13
Phase I Products/Combination Treatment Modalities 14
Retrophin Inc. - Early Stage Pipeline Products 15
Preclinical Products/Combination Treatment Modalities 15
Retrophin Inc. - Drug Profiles 16
chenodiol 16
Product Description 16
Mechanism of Action 16
R&D Progress 16
oxytocin 17
Product Description 17
Mechanism of Action 17
R&D Progress 17
RE-021 19
Product Description 19
Mechanism of Action 19
R&D Progress 19
RE-024 21
Product Description 21
Mechanism of Action 21
R&D Progress 21
cosyntropin 22
Product Description 22
Mechanism of Action 22
R&D Progress 22
mecamylamine 23
Product Description 23
Mechanism of Action 23
R&D Progress 23
RE-001 24
Product Description 24
Mechanism of Action 24
R&D Progress 24
RE-003 25
Product Description 25
Mechanism of Action 25
R&D Progress 25
Retrophin Inc. - Pipeline Analysis 26
Retrophin Inc. - Pipeline Products by Target 26
Retrophin Inc. - Pipeline Products by Route of Administration 27
Retrophin Inc. - Pipeline Products by Molecule Type 28
Retrophin Inc. - Pipeline Products by Mechanism of Action 29
Retrophin Inc. - Recent Pipeline Updates 30
Retrophin Inc. - Dormant Projects 32
Retrophin Inc. - Locations And Subsidiaries 33
Head Office 33
Other Locations & Subsidiaries 33
Appendix 34
Methodology 34
Coverage 34
Secondary Research 34
Primary Research 34
Expert Panel Validation 34
Contact Us 35
Disclaimer 35
List of Tables
Retrophin Inc., Key Information 5
Retrophin Inc., Key Facts 5
Retrophin Inc. - Pipeline by Indication, 2014 7
Retrophin Inc. - Pipeline by Stage of Development, 2014 8
Retrophin Inc. - Monotherapy Products in Pipeline, 2014 9
Retrophin Inc. - Partnered Products in Pipeline, 2014 10
Retrophin Inc. - Partnered Products/ Combination Treatment Modalities, 2014 11
Retrophin Inc. - Phase III, 2014 12
Retrophin Inc. - Phase II, 2014 13
Retrophin Inc. - Phase I, 2014 14
Retrophin Inc. - Preclinical, 2014 15
Retrophin Inc. - Pipeline by Target, 2014 26
Retrophin Inc. - Pipeline by Route of Administration, 2014 27
Retrophin Inc. - Pipeline by Molecule Type, 2014 28
Retrophin Inc. - Pipeline Products by Mechanism of Action, 2014 29
Retrophin Inc. - Recent Pipeline Updates, 2014 30
Retrophin Inc. - Dormant Developmental Projects,2014 32
Retrophin Inc., Other Locations 33 



                                

To request a free sample copy of this report, please complete the form below.

We never share your personal data. Privacy policy
Interested in this report? Get your FREE sample now! Get a Free Sample
Choose License Type
Single User - US $1500
Multi User - US $3000
Hexareeasearch Know

Did you know?

Research Assistance

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Why to buy from us

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Information security

Your personal and confidential information is safe and secure.

verify